Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride

Details for Australian Patent Application No. 2004216258 (hide)

Owner Eli Lilly and Company

Inventors Remick, David Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2004216258

PCT Pub. Number WO2004/075894

Priority 60/450,233 25.02.03 US; PCT/IB03/03349 16.07.03 IB

Filing date 21 January 2004

Wipo publication date 10 September 2004

Acceptance publication date 19 October 2006

International Classifications

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

C07D 295/092 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/075894 Priority application(s): WO2004/075894

19 October 2006 Application Accepted

  Published as AU-B-2004216258

15 February 2007 Standard Patent Sealed

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216264-Automatically opening medical device package and method of manufacture

2004216253-Tissue separating and localizing catheter assembly